Chemotherapy plus local treatment in the management of intraocular retinoblastoma

Archives of Ophthalmology

Volumn 114, Issue 11, 1996, Pages 1348-1356

  Murphree, A Linn ^a,b   Villablanca, Judith G ^a,b   Deegan III, William F ^a,b   Sato, Judith K ^a,b   Malogolowkin, Marcio ^a,b   Fisher, Anita ^a,b   Parker, Ricardo ^c   Reed, Eddie ^c   Gomer, Charles J ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; VINCRISTINE SULFATE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RADIATION HAZARD; RETINOBLASTOMA; TREATMENT OUTCOME;

EID: 0029909675     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140548005     Document Type: Article

References (30)

1. Eng C, Lin FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85:1121-1128.
2. MacFaul PA, Bedford MA. Ocular complications after therapeutic irradiation. Br J Opthalmol. 1970;54:237-247.
3. Imhof SM, Mounts MP, Hofman P, et al. Quantification of orbital and midfacial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology. 1996;103:263-268.
4. Messmer EP, Sauerwein W, Heinrich T, et al. New and recurrent tumor foci following local treatment as well as external beam radiotherapy radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol. 1990;228:426-431.
5. White L. The role of chemotherapy in the treatment of retinoblastoma. Retina. 1983;3:194-199.
6. Haye C, Desjardins L, Elmaleh C, et al. Prognosis and treatment of retinoblastoma: 105 cases treated at Institut Curie. Ophthalmic Paediatr Genet. 1989; 10:151-155.
7. Bin P, Boddy AV, English MW, et al. The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in paediatric patients: a review. Anticancer Res. 1994;14:2279-2283.
8. Gaynon PS. Carboplatin in pediatric malignancies. Semin Oncol. 1994;21(5 suppl 12):65-76.
9. Cairo MS. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors. Semin Oncol. 1995;22(3 suppl 7):23-27.
10. Lewis IJ, Strauss MC, Pearson A, Pinkerton CR, Stevens R. Phase II study of carboplatin in childhood tumors. Proc Am Soc Clin Oncol. 1993;12:A1413. Abstract.
11. Riccardi R, Riccardi A, DiRocco C, et al. Cerebrospinal fluid pharmacokinetics of carboplatin in children with brain tumors. Cancer Chemother Pharmacol. 1992;30:21.
12. Doz F, Neuenschwander S, Plantaz D, et al. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol. 1995;13:902-909.
13. Hahn GM. Thermal enhancement of the actions of anticancer agents. In: GM Hahn, ed. Hyperthemia and Cancer. New York, NY: Plenum Publishing Corp; 1982:55-86.
14. Da Silva VF, Raaphorst GP, Goyal R, Feeley M. Drug cytotoxicity at elevated temperature: in vitro study on the U-87MG glioma cell line. J Neurosurg. 1987; 67:885-888.
15. Herman TS, Teicher BA. Summary of studies adding systemic chemotherapy to local hyperthermia and radiation. Int J Hyperthermia. 1994;10:443-449.
16. Tapazoglu E, Cohen JD, Schmitt CL, Khatara A, Sapareto SA, Robins HI. Whole body hyperthermia and carboplatin: cytotoxicity for murine leukemia and normal marrow. Br J Cancer. 1991;64:528-530.
17. Murphree AL, Cote M, Gomer CJ. The evolution of photodynamic therapy techniques in the treatment of intraocular tumors. Photochem Photobiol. 1987;46: 919-923.
18. Reed E, Sauerhoff S, Poirier MC. Quantitation of platinum-DNA binding in human tissues following therapeutic levels of drug exposure: a novel use of graphite furnace spectrometry. Atomic Spectroscopy. 1988;9:93-95.
19. Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Natl Acad Sci U S A. 1987;84: 5024-5028.
20. McCormick B, Ellsworth R, Abramson D, Losasso T, Grabowski E. Results of external beam radiotherapy for children with retinoblastoma: a comparison of two techniques. J Pediatr Ophthalmol Strabismus. 1989;26:239-243.
21. Kinyoun JL, Zamber RW, Lawrence BS, Barlow WE, Arnold AM. Photocoagulation treatment for clinically significant radiation macular oedema. Br J Ophthalmol. 1995;79:144-149.
22. Elsas T, Thorud E, Jetne V, Conradi IS. Retinopathy after low dose irradiation for an intracranial tumor of the frontal lobe: a case report. Acta Ophthalmol. 1988;66:65-68.
23. Amoaku WM, Archer DB. Cephalic radiation and retinal vasculopathy. Eye. 1990; 4:195-203.
24. Archer DB, Amoaku WM, Gardiner TA. Radiation retinopathy: clinical, histopathological, ultrastructural and experimental correlations. Eye. 1991;5:239-251.
25. O'Brien ME, Tonge K, Blake P, Moskovic E, Wiltshaw E. Blindness associated with high-dose carboplatin. Lancet. 1992;339:558.
26. Rankin EM, Pitts JF. Ophthalmic toxicity during carboplatin therapy. Ann Oncol. 1993;4:337-338.
27. Winick NJ, McKenna RW, Shuster JJ, et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol. 1993;11:209-217.
28. Tucker MA, Meadows AT, Boice JD Jr, et al. Cancer risk following treatment of childhood cancer. In: Boice JD Jr, Fraumeni JF Jr, eds. Radiation Carcinogenesis, Epidemiology and Biological Significance. New York, NY: Raven Press; 1984:211-224.
29. Wolter JR. Growth retardation of the orbital region after radiation treatment of retinoblastoma: causing a very typical physiognomy. J Pediatr Ophthalmol Strabismus. 1974;11:125-128.
30. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996; 114:1321-1328.